Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Sign in
Sign in

Study: Reprogrammed blood vessels spur spread of cancer

A team of researchers from the German Cancer Research Center uncovered an activated form of a signaling molecule in blood vessels that can reprogram itself to spread cancer.

Researchers have known endothelial cells, which line the inner wall of blood vessels, play an important role in the growth and spread of cancer.

The study, conducted by researchers at the German Cancer Research Center and the Medical Faculty Mannheim of Heidelberg University, may have uncovered the way endothelial cells promote growth in cancer cells.

Researchers found high levels of the activated form of a signaling molecule called Notch when they examined blood vessel lining from lung, breast and bowel tumors, finding much higher levels of the molecule in tumor cells than in cells from healthy organs.

Notch works to regulate the development of organs in embryos and is the signaling protein in adults that regulates the activity of blood stem cells. The study suggests higher levels of Notch activation in the tumor endothelium encourage cancer to spread, resulting in a poorer prognosis for patients.

Although it was known that aberrant Notch signaling could turn cells cancerous, the new study discovered that the tumor cells themselves are responsible for Notch activation when in contact with endothelial cells.

Researchers found that the more activated Notch is in the tumor endothelium, the more cancer can spread into the bloodstream and lungs.

"Taken together, the results show a very clear picture," Andreas Fischer, a medical researcher from the Helmholtz University Junior Research Group, said in a press release. "The tumor cells promote their spread in the body in multiple ways by activating Notch and thus reprogramming endothelial cells for their own purposes. We therefore wanted to find out if we could interrupt this disastrous mechanism."

Fischer and his team were able to block Notch in mice with an antibody in the contact molecule VCAM1, which resulted in less cancer spread to the lungs and dampened the amount of immune cells invading the tumor to promote growth.

"Notch is a universal signaling molecule and this makes it difficult to exert therapeutic influence on it without interfering with vital processes," Fischer said. "But a targeted short-term use of blocking antibodies might be a promising approach for suppressing the dangerous spread of tumors."

The study was published in Cancer Cell.

March 3, 2017


0
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote

We use "cookies*  to ensure the functionality of our website, recognise your browser or device, learn more about your interests, and provide you with essential features and services and for additional purposes, including:

Recognising you when you sign-in to use our services. This allows us to provide you with product recommendations, display personalised content, and provide other customised features and services.
Keeping track of your specified preferences. You may set your preferences through Your Account..
Keeping track of items stored in your shopping basket and personal cabinet.
Conducting research and diagnostics to improve ChemDiv’s content, products, and services.
Delivering content, including ads, relevant to your interests on ChemDiv’s site
Reporting. This allows us to measure and analyse the performance of our services.

By  cookies you give consent to the processing of your personal data, including transfer to third parties. Further information can be found in our privacy policy.

Accept all cookies